SACRAMENTO, California, March 3 /PRNewswire/ --
ROBODOC, a Curexo Technology Company, and IBM announced today that they have entered into a major patent Cross licensing agreement. The terms of the agreement were not disclosed by either party.
In addition to its current surgical robotics patents, this agreement gives ROBODOC, access to more than 40,000 patents in IBM'S Global Portfolio and particularly, IBM's surgical robotics patents.
Dan Cerutti, IBM's general manager of intellectual property, said, "IBM enjoys a reputation of innovation and invention for technologies related to computer-assisted medicine and surgery. We are pleased to share our innovations in these areas through patent cross licenses, especially with forward-thinking companies such as ROBODOC."
"This agreement provides us with a significant improvement in our freedom of action in the Surgical Robotics and Information Management field. We intend to continue building our own intellectual property portfolio on an on-going basis," commented Dr. Ramesh Trivedi, President and CEO of ROBODOC.
IBM has earned the most U.S. patents for 15 consecutive years. For more information on IBM, please visit http://www.ibm.com.
ROBODOC, a Curexo Technology Company is the United States-based subsidiary of Korea-based Curexo Inc. (KOSDAQ: 060280.KQ). Its main research facility is in the U.S. and it reaches markets throughout the world.
About ROBODOC
ROBODOC, develops, manufactures, and markets a fully automated surgical robotic system for use in orthopaedic surgery. The system includes two components; ORTHODOC, a computer workstation equipped with proprietary software for preoperative surgical planning, and ROBODOC, a computer-controlled surgical robotic assistant for use in hip and knee replacement as well as other orthopaedic procedures. ROBODOC made medical history in 1992 by assisting in a Total Hip Arthroplasty (THA) procedure. Since that time, the ROBODOC system has been used in over 20,000 surgical procedures assisting surgeons around the world. The ROBODOC Surgical Assistance System is currently in its final stage of review and clearance by the FDA.
ROBODOC(R) and ORTHODOC(R) are registered trade marks of Curexo Technology Corporation.
1433 N. Market Blvd., Suite 1, Sacramento, CA 95834 http://www.robodoc.com Contact: Dr. R.C. Trivedi President & CEO ROBODOC(R) A Curexo Technology Company +1-916-285-9943 x 527 or Ms. Sheila Shah Marketing Communications ROBODOC(R) A Curexo Technology Company +1-916-285-9943 X 510 press@robodoc.com Web site: http://www.robodoc.com http://www.ibm.com
Dr. R.C. Trivedi, President & CEO, +1-916-285-9943, ext. 527, or Ms. Sheila Shah, Marketing Communications, +1-916-285-9943, ext. 510, press@robodoc.com, both of ROBODOC
Comments